Judge Nixes Infosint's $15M Patent Win Over Citalopram
A federal judge ruled Thursday that an Infosint SA patent related to the manufacture of antidepressant citalopram was invalid, throwing out an earlier $15 million infringement verdict against defendants H. Lundbeck...To view the full article, register now.
Already a subscriber? Click here to view full article